Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T16:28:13.280Z.
Calculation as of: 2026-10-06T16:28:13.280Z.
Quote observation: 2026-10-06T16:25:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e2377adf8a67d9885493687def1e39da55984393789cfa4a1880694b5c46c4a2
PEG RATIO
N/A
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | $445.14M | N/A | N/A | N/A | N/A |
| NeuroPace, Inc. (NPCE)vs › | $446.12M | N/A | N/A | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $448.58M | N/A | N/A | N/A | N/A |
| Assembly Biosciences, Inc. (ASMB)vs › | $440.34M | N/A | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $439.96M | N/A | N/A | N/A | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $435.83M | N/A | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $431.16M | N/A | 4.41 | 4.41 | 4.41 |
| NRC Health (NRC)vs › | $462.12M | N/A | 6.07 | 3.14 | 2.42 |
| Sight Sciences, Inc. (SGHT)vs › | $468.47M | N/A | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $420.85M | N/A | N/A | N/A | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute